Physician profile
Lynley Durrett
NPI 1073501169
$3,376.24
in general payments reported to CMS, 2019-2025
32 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $454 · 2021: $815 · 2022: $594 · 2023: $325 · 2024: $543 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $556.48 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $512.23 | 2019-2023 | Orilissa |
| Hologic Sales and Service, LLC | $373.19 | 2020-2024 | Aptima, Acessa Provu System |
| Mayne Pharma Commercial LLC | $205.75 | 2021-2025 | |
| Therapeuticsmd, INC. | $191.00 | 2019-2022 | |
| Avanos Medical | $165.59 | 2019-2024 | On-Q* Pump and Accessories |
| Shield Therapeutics INC | $160.03 | 2023-2025 | Accrufer |
| Millicent US INC | $121.56 | 2021-2025 | Intrarosa, Femlyv |
| Pfizer INC. | $119.83 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.73 | 2019-2025 | |
| Medtronic, INC. | $111.05 | 2021-2025 | Interstim |
| Scynexis, INC. | $96.70 | 2022 | |
| Smith+Nephew, INC. | $83.72 | 2024 | Stravix, Grafix |
| Boston Scientific Corporation | $67.86 | 2024-2025 | Axonics, Obtryx System - Curved |
| Sumitomo Pharma America, INC. | $48.10 | 2023-2024 | Myfembree |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $44.71 | 2021-2025 | Gardasil 9, Gardasil |
| Myovant Sciences INC. | $42.74 | 2021-2022 | |
| Stryker Corporation | $42.61 | 2020 | |
| Avion Pharmaceuticals | $41.43 | 2021-2023 | Balcoltra |
| Evofem Biosciences, INC. | $33.59 | 2021-2022 | |
| Acessa Health INC. | $29.17 | 2020-2021 | |
| Mycovia Pharmaceuticals, INC. | $27.91 | 2023 | Vivjoa |
| Axonics, INC. | $25.55 | 2020 | |
| Baxter Healthcare | $24.32 | 2024 | Perclot |
| Exact Sciences Corporation | $22.56 | 2025 | The Cologuard Plus Collection Kit |
| Duchesnay USA Incorporated | $19.78 | 2019 | |
| Coopersurgical, INC. | $18.06 | 2023 | Mara Console |
| Lupin INC. | $17.60 | 2020 | |
| Amag Pharmaceuticals, INC. | $15.21 | 2019 | |
| Mimedx Group, INC. | $15.20 | 2024 | |
| Daiichi Sankyo INC. | $14.62 | 2019 | |
| Dysis Medical, INC. | $12.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynley Durrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.